IR with t½ ≥ 24 h [NCA / SHAM]

posted by Helmut Homepage – Vienna, Austria, 2025-10-14 12:30 (253 d 14:48 ago) – Posting: # 24451
Views: 2,671

Hi Darborn,

❝ When calculating AUC0–∞, I know some regulatory agencies use extrapolation while others use the actual value. For a long half-life pro­duct truncated at 72 hours, should I use AUC0–t or AUC0–72 for bioequivalence assessment? :confused:

If it is an IR-product with a half life ≥ 24 h, AUC0–72 (see this article about ICH M13A and the linked references).

If t½ < 24 h, the primary metric is AUC0–t. You have to estimate AUC0– as well but only to assess the extrapolated fraction (AUC0–t should cover ≥ 80 % of AUC0– in ≥ 80 % of observations).

❝ I think these two value may differ when 72h has a LLOQ.

Of course. See this presentation (slides 19–24).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
126 visitors (0 registered, 126 guests [including 21 identified bots]).
Forum time: 03:18 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5